Xiaoying Huang

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 6

Top Venues

Journal of cellular and molecular medicine

FEBS open bio

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cardiovascular research

Affiliated Hospital of Wenzhou Medical University & Key Laboratory of Heart and Lung

Zhejiang Hospital of Traditional Chinese Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Affiliated Hospital of Wenzhou Medical University & Key Laboratory of Heart and Lung Sep 1o 2002

China

professor :: Division of Pulmonary Medicine

Education History

Zhejiang Hospital of Traditional Chinese Medicine Sep 1o 2008 - Jun 30o 2011

China

PHD :: Traditional and western medicine combined with clinical

Publications

Ruixuan Zheng, Lexiang Zhang, Rokshana Parvin, Lihuang Su, Junjie Chi, Keqing Shi, Fangfu Ye, Xiaoying Huang
Progress and Perspective of CRISPR-Cas9 Technology in Translational Medicine. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Ruixuan Zheng, Tingting Xu, Ya Lin, Xiaoying Huang
Are endothelial cell proliferation and mesenchymal transition as distinguishing characteristics of three-week SuHx mice model? Cardiovascular research (2023)
Xiuchun Li, Yaxin Zhang, Lihuang Su, Luqiong Cai, Chi Zhang, Jianhao Zhang, Junwei Sun, Mengyu Chai, Mengsi Cai, Qian Wu, Chi Zhang, Xiaoqing Yan, Liangxing Wang, Xiaoying Huang
FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19. Journal of cellular and molecular medicine 26 (10) (2022)
Meibin Wang, Lihuang Su, Junwei Sun, Luqiong Cai, Xiuchun Li, Xiayan Zhu, Lanlan Song, Jingyin Li, Shuolan Tong, Qinlian He, Mengsi Cai, Lehe Yang, Yanfan Chen, Liangxing Wang, Xiaoying Huang
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARγ. Journal of cellular and molecular medicine 26 (4) (2022)
Mengsi Cai, Xiuchun Li, Haoru Dong, Ying Wang, Xiaoying Huang
CCR7 and its related molecules may be potential biomarkers of pulmonary arterial hypertension. FEBS open bio 11 (6) (2021)
Shuangquan Yan, Yiran Wang, Panpan Liu, Ali Chen, Mayun Chen, Dan Yao, Xiaomei Xu, Liangxing Wang, Xiaoying Huang
Baicalin Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension to Improve Hypoxic Cor Pulmonale by Reducing the Activity of the p38 MAPK Signaling Pathway and MMP-9. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)

Xiaoying Huang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaoying Huang